Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope and definitions
1.3 Base estimates and working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Neurovascular devices industry 360º synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Process trends
2.1.4 Therapeutic application trends
2.1.5 End-use trends
2.1.6 Regional trends
Chapter 3 Neurovascular Devices Industry Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing number of brain aneurysm and ischemic strokes in North America
3.2.1.2 Rising demand for minimally invasive surgical procedures
3.2.1.3 Technological advancement in neurovascular treatments
3.2.1.4 Government initiatives to modernize healthcare infrastructure across the globe
3.2.2 Industry pitfalls & challenges
3.2.2.1 Need for designing more effective and low-cost treatments
3.2.2.2 Challenges involved in commercialization of neurovascular devices across developing and underdeveloped economies
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By process
3.3.3 By therapeutic application
3.3.4 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Supply chain analysis
3.7 Regulatory and reimbursement landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of innovation leaders, 2021
4.3.1 Johnson & Johnson Inc
4.3.2 Medtronic
4.3.3 Stryker
4.3.4 Terumo Corporation
4.4 Strategy dashboard
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Neurovascular Devices Market, By Product
5.1 Key product trends
5.2 Embolic coils
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.2.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.3 Carotid stents
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.4 Intracranial stents
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.5 Catheters
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.6 Embolic protection devices
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.7 Flow diverters
5.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.7.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.8 Neurothrombectomy devices
5.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.8.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.9 Intrasaccular devices
5.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.9.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.10 Balloon systems
5.10.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.10.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.11 Stent retrievers
5.11.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.11.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.12 Guidewires
5.12.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.12.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
5.13 Others
5.13.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.13.2 Market estimates and forecast, 2018 - 2032 (000’ Units)
Chapter 6 Neurovascular Devices Market, By Process
6.1 Key process trends
6.2 Neurothrombectomy procedure
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Cerebral angiography technique
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Carotid endarterectomy (CEA)
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Stenting
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Microsurgical clipping
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Coiling
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Flow diversion
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.9 Others
6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Neurovascular Devices Market, By Therapeutic Application
7.1 Key therapeutic application trends
7.2 Brain aneurysm
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Stenosis
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Ischemic stroke
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.5 Others
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Neurovascular Devices Market, By End-use
8.1 Key end-use trends
8.2 Hospitals
8.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.3 Ambulatory surgical centers
8.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.4 Clinics
8.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
8.5 Others
8.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 9 Neurovascular Devices Market, By Region
9.1 Key regional trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Russia
9.3.7 Turkey
9.3.8 Netherlands
9.3.9 Belgium
9.3.10 Austria
9.3.11 Switzerland
9.3.12 Poland
9.3.13 Czech Republic
9.3.14 Hungary
9.3.15 Portugal
9.3.16 Greece
9.3.17 Romania
9.3.18 Bulgaria
9.3.19 Denmark
9.3.20 Sweden
9.3.21 Norway
9.3.22 Finland
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Singapore,
9.4.7 Hong Kong
9.4.8 Taiwan,
9.4.9 Indonesia
9.4.10 Cambodia
9.4.11 Philippines
9.4.12 Vietnam,
9.4.13 Malaysia
9.4.14 Thailand
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 MEA
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Asahi Intecc CO., LTD.
10.2 Integer Holdings Corporation
10.3 Johnson & Johnson Services, Inc.
10.4 Kaneka Medix Corp.
10.5 LivaNova PLC
10.6 Medtronic
10.7 MicroPort Scientific Corporation
10.8 Penumbra, Inc.
10.9 Stryker
10.10 Terumo Corporation
